Johnson & Johnson on Track for $100 Billion Revenue Milestone! I'm Holding on to My Shares!

After the spinoff of the consumer goods division Kenvue in 2023, Johnson & Johnson (i)(JNJ) has successfully reinvented itself as a pure innovation powerhouse for pharmaceuticals and medical technology. With a strategic multibillion-dollar investment, management supports its ambitious vision of achieving sustainable double-digit growth by 2030. For over $1 billion, J&J is massively expanding its Vision division in Jacksonville, Florida. Through state-of-the-art manufacturing and packaging technologies, as well as a new logistics center,...